← Eichor
Study identifier: NCT06454396 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

Condition: Hemodialysis Access Failure  ·  Sponsor: RenJi Hospital

PhaseN/A
Planned participants480
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study was aimed at evaluating the efficacy of different endovascular treatments for early and mid-stage clinical interventions in patients with autologous arteriovenous fistulae loss of function and the corresponding health economic value.

This description comes directly from the study's public registry record.

Talk to the study team

Jingpu Zhu  ·  +86-17520505530  ·  a8600809@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Renji HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06454396